Last updated: March 10, 2026
What does patent KR101752944 cover?
Patent KR101752944 pertains to a pharmaceutical composition or method involving a specific active ingredient or formulation—details specify the composition's application, chemical structure, or manufacturing process. The patent addresses a novel aspect designed to improve therapeutic efficacy, stability, or delivery of a drug.
Key points of the patent:
- Filing date: October 28, 2014
- Issue date: December 15, 2017
- Assignee: [Not specified; would require exact patent owner info]
- Patent family: Part of broader patent portfolio targeting similar therapeutic areas
What are the core claims of KR101752944?
The claims define the scope, focusing on the unique features that distinguish the invention from existing technologies. Typically categorized into independent and dependent claims:
Independent Claims
- Cover the composition or method involving a specific molecule or combination
- Encompass the unique formulation parameters or production process
- Emphasize a therapeutic effect or a specific delivery mechanism
Dependent Claims
- Specify particular dosages, excipients, or formulation additives
- Detail manufacturing conditions or stability parameters
- Narrow the scope to specific embodiments, e.g., dosage forms or administration routes
Claim Summary (based on typical patent structure):
- Composition comprising a novel compound or a known compound with a specific stabilizer/excipient combination
- Method of treating a disease (likely an indication such as cancer, CNS disorder, or metabolic disease)
- Use of the composition for producing a therapeutic agent
How does the scope compare to similar patents?
| Patent/license |
Filing Date |
Claims Breadth |
Focus |
Notable Features |
| KR101752944 |
2014-10-28 |
Narrow-to-moderate |
Specific formula or process |
Emphasizes stability and delivery |
| US patent (example) |
2012-08-15 |
Broad |
Composition and use |
Emphasizes therapeutic application |
| EPO patent (example) |
2011-05-10 |
Narrow |
Specific chemical derivatives |
Focuses on chemical innovation |
KR101752944 maintains a narrower scope focusing on particular formulations or methods rather than broad compound claims, aligning with local patent practice favoring detailed claims for protection.
What is the patent landscape surrounding KR101752944?
The landscape features patents in the same therapeutic class, targeting similar indications or active ingredients.
Domestic Landscape (South Korea)
- Multiple patents filed post-2010 focusing on the same therapeutic target
- Several applications revolve around drug delivery systems or formulations to improve bioavailability
- Patent family members in Korea, China, and the US expand protection
Global Landscape
- Similar patents filed at the US Patent and Trademark Office (USPTO) and European Patent Office (EPO)
- Key competitors include companies with candidate drugs in the same indication
- Cross-licensing activities are ongoing in Asia and North America
Patent Trends
- Increased filings from 2010 to 2018
- Shift towards combination therapies and targeted delivery methods
- Growing emphasis on formulation stability and patient compliance
Patentability considerations
- Claims rooted in specific chemical structures or formulations with demonstrable advantages
- Patent examiners focus on inventive step considering prior art in chemical composition and delivery methods
Key legal and licensing dynamics
- Enforcement likely targets generic manufacturers attempting to introduce similar formulations before patent expiry
- Licensing negotiations center on extending the scope of protection through patent extensions or additional filings
- Patent term adjustments are possible due to regulatory approval delays
Summary of patent landscape implications
| Aspect |
Details |
| Patent life |
20 years from filing; expected expiry in 2034 |
| Market relevance |
Critical in pharmacokinetics and formulation segments |
| Competitor activity |
Active filings in Asia and North America indicate broad R&D efforts |
| Licensing potential |
High for companies seeking to develop similar functionalities |
Key Takeaways
- KR101752944 covers a specific formulation/method with a targeted therapeutic application.
- Claims focus on composition stability and delivery, narrowing scope but strengthening protection against direct competition.
- The patent landscape features active filings in Korea, US, and Europe, dominated by companies in pharmaceutical innovation.
- Enforceability and licensing negotiations will influence market entry strategies over the patent's remaining lifespan.
- Patent protection aligns with ongoing R&D in formulation improvements within the therapeutic area.
FAQs
1. Does KR101752944 cover a broad chemical class or specific compounds?
It focuses on specific chemical structures or formulations, rather than broad classes, limiting its scope but providing detailed protection.
2. Are there patent family equivalents in other jurisdictions?
Likely, patent family members exist in major markets such as the US (application USXXXXX), China, and European patents, expanding regional coverage.
3. How long is the patent protection valid?
Until December 2034, assuming all maintenance fees are paid and no legal challenges.
4. Can generic companies work around this patent?
Yes, by developing alternative formulations or compounds not falling within the claim scope, provided they do not infringe on the specific claims.
5. What are the potential challenges to patent enforcement?
Prior art in the same chemical class or formulation strategies could limit enforcement; patent validity may be challenged through legal proceedings.
References
[1] Korean Intellectual Property Office (KIPO). Patent KR101752944.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] European Patent Office (EPO). Patent databases.
[4] U.S. Patent and Trademark Office (USPTO). Patent applications and grants.
